THERAPEUTICS NEWS

Pages 1 | 2 | Previous | Next

Global perspective on research
Optician clincial editor Bill Harvey selects a few research papers of interest presented at this year's biggest research conference25 May 2007

Independents take lead in therapeutics
Independent practitioners are more likely to be early adopters of therapeutic prescribing than those working in multiples, according to a new survey carried out by City University for the College of Optometrists (News, January 19). The survey suggests that 10 per cent of independent practitioners are currently training to become additional supply optometrists compared with 4 per cent of those in multiple practice. Hospital optometrists are most likely to be undergoing this training (16 per cent) and locums are least likely (2 per cent). Fewer optometrists are training to be supplementary prescribers but uptake is again higher among those working in independent practice than in multiples (5 per cent versus 2 per cent). Overall, the uptake of training for an extended prescribing role is low. However, relatively few practitioners responding to the survey said they had no interest in prescribing or had no intention of undergoing further training in therapeutics. <26 January 2007

Lucentis and Avastin could be compared
The efficacy of colon cancer drug Avastin (bevacizumab) in treating wet-AMD could be compared to wet-AMD drug Lucentis (ranibizumab) in a US government clinical study. 05 October 2006

Cost deters check-ups
Over a third of Britons are risking their health by putting off important health checks, according to an independent nationwide survey conducted on behalf of HSF Health Plan.29 September 2006

Antibiotics unnecessary for childhood conjunctivitis
Antibiotics are not necessary for most children with acute infective conjunctivitis. 14 July 2006

Allergan and Alcon reach patent agreement
Allergan and Alcon have settled a patent infringement lawsuit in a US District COurt contending that Alcon's proposed brimonidine 0.15% product infringes two brimonidine-related patents owned by Allergan.09 March 2006

Clinicians seek ambitious goal
Research into an eye test that could one day help prevent heart attacks has received a A$300,000 (128,000) grant from drugs giant Pfizer. 10 February 2006

Comment from Viteyes' UK distributor
Viteyes' UK distributor Butterflies Healthcare comments on the Drugs and Therapeutics Bulletin report:07 February 2006

Benefits of nutritional supplements for macular degeneration 'oversold'
Nutritional supplements claiming to improve eye health may be in breach of UK medicines legislation according to this month's Drugs and Therapeutics Bulletin.06 February 2006

Therapeutics for beginners
Practitioners who want to make a start in therapeutic and anterior eye practice are targeted in the BCLA's next half-day CET course. 03 February 2006